The Liposomal Drugs market was valued at USD 5.31 Billion in 2024 and is expected to reach USD 10.21 Billion by 2032, growing at a CAGR of 8.5% (2025-2032). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.